Brief: Astonea Labs Approves Acquisition Of Equity Stake In Damaira Pharmaceuticals
03/12/2025 13:55
Dec 3 (Reuters) - Astonea Labs ASTD.BO: APPROVES ACQUISITION OF EQUITY STAKE IN DAMAIRA PHARMACEUTICALS Source text: ID:nBSE4mrgpP Further company coverage: ASTD.BO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astonea Labs
See all newsBrief: Astonea Labs Approves Incorporation Of Longevity Science As Unit Of Co
Brief: Astonea Labs Completes SBDMA Yemen Inspection Of Haryana Manufacturing Facility
Brief: Astonea Labs Says Inadvertent Fire Incident Took Place On 27Th April 2026
Brief: Astonea Labs Buys 25.74% Equity Stake In Damaira Pharmaceuticals
Brief: Astonea Labs Executes Sale Deed For Land Acquisition In Haryana